192 related articles for article (PubMed ID: 11708414)
1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Kaltwasser JP; Kessler U; Gottschalk R; Stucki G; Möller B
J Rheumatol; 2001 Nov; 28(11):2430-6. PubMed ID: 11708414
[TBL] [Abstract][Full Text] [Related]
2. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
4. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
5. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
6. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
Karkouti K; McCluskey SA; Ghannam M; Salpeter MJ; Quirt I; Yau TM
Can J Anaesth; 2006 Jan; 53(1):11-9. PubMed ID: 16371604
[TBL] [Abstract][Full Text] [Related]
8. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
Bolger AP; Bartlett FR; Penston HS; O'Leary J; Pollock N; Kaprielian R; Chapman CM
J Am Coll Cardiol; 2006 Sep; 48(6):1225-7. PubMed ID: 16979010
[TBL] [Abstract][Full Text] [Related]
9. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
10. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
[TBL] [Abstract][Full Text] [Related]
11. [The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis].
Zhu Y; Ye D; Huang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):587-90. PubMed ID: 11225250
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
14. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
Westad S; Backe B; Salvesen KA; Nakling J; Økland I; Borthen I; Rognerud Jensen OH; Kolås T; Løkvik B; Smedvig E
Acta Obstet Gynecol Scand; 2008; 87(9):916-23. PubMed ID: 18720044
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of patients with chronic renal allograft rejection and anemia.
Rebollo P; Baltar JM; Campistol JM; Ortega T; Ortega F
J Nephrol; 2004; 17(4):531-6. PubMed ID: 15372415
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
Keast DH; Fraser C
Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
[TBL] [Abstract][Full Text] [Related]
17. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
18. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
19. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
20. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]